|
|
2024's Stock Market Performance
|
|
2024's Stock Market Performance
|
2024's Large Cap Stocks Performance
Here are the best and worst performing Large-Cap Stocks of 2024.
The Large-Cap Company is defined with the market capitalization, trading above 5 billion dollars U.S. as of 11/04/26.
2024's Mid Cap Stocks Performance
Here are the best and worst performing companies of 2024 with the market capitalization, trading between 500 million U.S. dollars and 5 billion dollars U.S. respectively, as of 11/04/26.
2024's Small Cap Stocks Performance
The table shows the best and worst performing companies of 2024 with the market capitalization, trading between 50 million U.S. dollars and 500 million dollars U.S. respectively, as of 11/04/26.
2024's Micro Cap Stocks Performance
The list shows the best and worst performing companies of 2024 with the market capitalization, trading under 50 million U.S. dollars, as of 11/04/26.
Who are the 2024's Stock Market Losers?
WOLF
-84.60%
|
|
|
Wolfspeed Inc
Semiconductors Industry
WOLF
-84.60%
is an innovator of wide bandgap semiconductors
|
CTNT
-84.82%
|
|
|
Cheetah Net Supply Chain Service inc
Auto & Truck Parts Industry
CTNT
-84.82%
Cheetah Net Supply Chain Service Inc. operates as a third-party logistics provider by creating a marketplace platform that connects shippers with carriers, allowing them to efficiently and effectively manage their supply chain needs. They offer a variety of services such as transportation management, freight brokerage, and e-commerce solutions to streamline and optimize the movement of goods.
|
NCNA
-84.98%
|
|
|
Nucana Plc
Major Pharmaceutical Preparations Industry
NCNA
-84.98%
Nucana Plc is a pharmaceutical company that focuses on developing novel treatments for cancer and other diseases.
|
SPRB
-85.81%
|
|
|
Spruce Biosciences Inc
Major Pharmaceutical Preparations Industry
SPRB
-85.81%
The company develops enzyme replacement therapies for rare diseases and pursues regulatory approval for these treatments.
|
BLRX
-86.27%
|
|
|
Biolinerx Ltd
Major Pharmaceutical Preparations Industry
BLRX
-86.27%
Biolinerx Ltd is a biopharmaceutical company that focuses on discovering, developing, and commercializing novel therapeutics for various diseases. Their business model revolves around the research and development of innovative drug candidates, conducting clinical trials to assess their safety and efficacy, and obtaining regulatory approvals to bring these treatments to market. They aim to generate revenue through licensing agreements, strategic collaborations, and the sale of their therapeutics to patients or healthcare providers.
|
ELPW
-87.55%
|
|
|
Elong Power Holding Limited
Industrial Machinery and Components Industry
ELPW
-87.55%
Elong Power Holding Limited is a holding company incorporated in the Cayman Islands with subsidiaries operating in China.
|
QXO
-87.71%
|
|
|
Qxo Inc
Cloud Computing & Data Analytics Industry
QXO
-87.71%
QXO, Inc. is a building products distribution company operating in North America and Canada.
|
JBIO
-87.85%
|
|
|
Jade Biosciences Inc
Major Pharmaceutical Preparations Industry
JBIO
-87.85%
The company develops biologic therapies for autoimmune diseases using monoclonal antibodies.
|
STI
-90.04%
|
|
|
Suntrust Banks Inc
Commercial Banks Industry
STI
-90.04%
SunTrust Banks Inc operates as a financial holding company that provides a wide range of banking and financial services to individual and corporate clients. Its business model revolves around serving customers through various channels such as branches, digital platforms, and call centers, offering services including consumer and commercial banking, mortgage lending, wealth management, and investment banking. With a focus on delivering personalized solutions and growth-oriented strategies, SunTrust aims to meet the financial needs of its clients and build long-lasting relationships.
|
HSDT
-91.72%
|
|
|
Solana Company
Medical Equipment & Supplies Industry
HSDT
-91.72%
Helius Medical Technologies Inc is a company that operates on a subscription-based business model, providing medical technology solutions for the treatment of neurological symptoms and conditions through its proprietary platform known as PoNS. This includes offering PoNS devices and related therapy services to healthcare providers and patients, with an aim to improve patient outcomes and quality of life.
|
SVRE
-92.69%
|
|
|
Saverone 2014 Ltd
Cloud Computing & Data Analytics Industry
SVRE
-92.69%
The company commercializes SaverOne systems designed to deter mobile phone distracted driving.
|
NAAS
-93.06%
|
|
|
Naas Technology inc
Specialty Retail Industry
NAAS
-93.06%
Naas Technology Inc is a business-to-business (B2B) company that offers a software platform for creating, managing, and automating customer processes. Their business model revolves around providing customizable solutions to businesses, enabling them to streamline their operations, enhance customer experiences, and increase operational efficiencies.
|
BDRX
-93.98%
|
|
|
Biodexa Pharmaceuticals Plc
Major Pharmaceutical Preparations Industry
BDRX
-93.98%
Biodexa Pharmaceuticals Plc operates as a biopharmaceutical company that focuses on the research, development, and commercialization of innovative medical solutions. Their business model revolves around leveraging scientific expertise to bring new medicines to market and meet the healthcare needs of patients worldwide.
|
VCIG
-98.32%
|
|
|
Vci Global Limited
Professional Services Industry
VCIG
-98.32%
VCI Global Limited*s business model involves offering a range of services or products to customers. Further information is not provided to accurately describe their specific business operations.
|
CDT
-98.53%
|
|
|
Cdt Equity Inc
Major Pharmaceutical Preparations Industry
CDT
-98.53%
Conduit Pharmaceuticals Inc*s business model revolves around the development and commercialization of pharmaceutical products.
|
XXII
-98.63%
|
|
|
22nd Century Group inc
Tobacco Industry
XXII
-98.63%
22nd Century Group Inc is a company that operates in various sectors, including plant biotechnology, tobacco, cannabis, and hemp. They focus on developing and commercializing unique technology and products related to genetics, plant breeding, and agricultural science.
|
|
PREV.